Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Concurrent Chemoradiation Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776340
What this trial is testing

Induction PD-1 Inhibitor and Chemotherapy Followed by Chemoradiotherapy in Unresectable or Inoperable HPV-negative LA-HNSCC

Who this might be right for
HPV-unrelated Head and Neck Squamous Cell Carcinoma
Fudan University 104
Not applicableLooking for participantsNCT06349148
What this trial is testing

The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients

Who this might be right for
Cervical Cancers
SHUANG ZHENG JIA, PhD 50
Large-scale testing (Phase 3)UnknownNCT00411138
What this trial is testing

Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer

Who this might be right for
Endometrial Cancer
Leiden University 670
Testing effectiveness (Phase 2)Active Not RecruitingNCT07090031
What this trial is testing

Perioperative Treatment With TAS-102 in Combination With Oxaliplatin for Locally Advanced Rectal Cancer

Who this might be right for
EFSpCR Rate
Qingdao Central Hospital 49
Testing effectiveness (Phase 2)UnknownNCT05448885
What this trial is testing

Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 50
Testing effectiveness (Phase 2)Study completedNCT04380480
What this trial is testing

Percutaneous Endoscopic Gastrostomy Before Definitive Concurrent Chemoradiation Therapy for Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 63
Large-scale testing (Phase 3)Looking for participantsNCT05624996
What this trial is testing

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Who this might be right for
Locally Advanced Lung Non-Small Cell CarcinomaStage IIB Lung Cancer AJCC v8Stage III Lung Cancer AJCC v8
NRG Oncology 474
Testing effectiveness (Phase 2)Study completedNCT00520702
What this trial is testing

3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 168
Testing effectiveness (Phase 2)Study completedNCT00250211
What this trial is testing

Magnetic Resonance Spectroscopic Imaging (MRS) and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide

Who this might be right for
GlioblastomaGlioma
AHS Cancer Control Alberta 26
Testing effectiveness (Phase 2)UnknownNCT04182698
What this trial is testing

Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC

Who this might be right for
Patients With Non-small Cell Lung Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 90
Testing effectiveness (Phase 2)Study completedNCT02720614
What this trial is testing

Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
LIN QIANG 12
Testing effectiveness (Phase 2)Study completedNCT01312350
What this trial is testing

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Who this might be right for
Hypopharyngeal Cancer
Samsung Medical Center 40
Not applicableLooking for participantsNCT07711626
What this trial is testing

Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT

Who this might be right for
Head and Neck NeoplasmsXerostomiaCancer-related Fatigue+1 more
Tzu Chi University 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05904015
What this trial is testing

The Study of Envafolimab Combined With Concurrent Chemoradiotherapy In LS-SCLC

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 80
Testing effectiveness (Phase 2)UnknownNCT04982549
What this trial is testing

Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC

Who this might be right for
Unresectable Stage III NSCLC
Shandong Cancer Hospital and Institute 35
Testing effectiveness (Phase 2)UnknownNCT00506623
What this trial is testing

Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer

Who this might be right for
Rectal NeoplasmNeoadjuvant Therapy
National Cancer Center, Korea 48
Large-scale testing (Phase 3)Active Not RecruitingNCT07306663
What this trial is testing

Sintilimab Combined With Chemotherapy Induction Therapy Followed by CCRT vs. CCRT for Esophageal Cancer: A Randomized Controlled Phase Ⅲ Clinical Study

Who this might be right for
Esophageal Cancer
Jiangsu Cancer Institute & Hospital 242
Not applicableUnknownNCT04161352
What this trial is testing

Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC

Who this might be right for
Unresectable Stage III NSCLC
Zhejiang Cancer Hospital 500
Testing effectiveness (Phase 2)Looking for participantsNCT06532279
What this trial is testing

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer

Who this might be right for
Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8+38 more
NRG Oncology
Testing effectiveness (Phase 2)UnknownNCT05351320
What this trial is testing

WX-0593 Combined With Concurrent Chemoradiotherapy in Unresectable Locally Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Jinming Yu 40
Next Page
98